Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients

OBJECTIVES: To compare the total number of adverse events (AEs) before and after mesenchymal stromal cell (MSC) infusion in refractory JIA and to evaluate its effectiveness. METHODS: Single-centre Proof of Mechanism Phase Ib, open label intervention study in JIA patients previously failing all biolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Swart, Joost F, de Roock, Sytze, Nievelstein, Rutger A J, Slaper-Cortenbach, Ineke C M, Boelens, Jaap J, Wulffraat, Nico M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758577/
https://www.ncbi.nlm.nih.gov/pubmed/31070229
http://dx.doi.org/10.1093/rheumatology/kez157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758577/
https://www.ncbi.nlm.nih.gov/pubmed/31070229
http://dx.doi.org/10.1093/rheumatology/kez157

Ejemplares similares